Charles River Laboratories International, Inc. (CRL)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 231.77 |
| Open | 234.15 |
| Bid | 92.60 x 900 |
| Ask | 259.99 x 1100 |
| Day's range | 226.28 - 236.11 |
| 52-week range | 217.20 - 460.21 |
| Volume | |
| Avg. volume | 574,593 |
| Market cap | 11.819B |
| Beta (5Y monthly) | 1.27 |
| PE ratio (TTM) | 28.35 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Here's Why You Should Retain Charles River (CRL) Stock for Now
Investors are optimistic about Charles River (CRL) due to the strong first-quarter results.
- Zacks
Charles River (CRL) DSA Arm Prospers, Currency Headwind Stays
Charles River (CRL) broadens the scope of the products and services across the drug discovery and early-stage development continuum through focused acquisitions.
- Zacks
Charles River (CRL) Q1 Earnings Top, Gross Margin Falls
Charles River (CRL) Q1 results highlight 9.8% organic revenue growth, driven by strength across all three segments.
© 2022 Yahoo. All rights reserved.
